Bifilac Capsule

BIFILAC Capsule contains Streptococcus faecalis T-110 JPC, Clostridium butyricum TO-A, Bacillus mesentericus TO-A-JPC, which are patented strains licensed from TOA Pharmaceuticals Co. Ltd., Japan, and Lactic acid bacillus (Lactobacillus sporogenes), which is a time-tested probiotic strain. Through their symbiotic action, they produce certain factors that inhibit bad micro-organisms and, in addition, also produce a bifidogenic nutrient that helps in increasing the count of beneficial micro-organisms in the intestine.